Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

U.S. health agencies announced that the food industry will begin "phasing out" eight artificial food dyes in the coming years.

The U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) have announced actions to phase out ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

The chief executive of Johnson & Johnson has warned that potential ... wide-ranging tariffs announced this month, but the Trump administration has made it clear that it is considering using ...

investors cite weak medical device sales Depression drug Spravato expected to generate $3 billion-3.5 billion in annual sales by 2028 April 15 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab ...